Combinatorial Effect of Prophylactic Interventions for Post-ERCP Pancreatitis among Patients with Risk Factors: A Network Meta-Analysis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The combinatorial effects of prophylactic methods for postendoscopic retrograde cholangiopancreatography pancreatitis (PEP) in patients with risk factors remain unclear. In this network meta-analysis, we compared the efficacy of various prophylactic strategies to decrease the risk of PEP among patients with risk factors. Methods: A systematic review was performed to identify randomized controlled trials from PubMed, Embase, and the Cochrane Library through July 2021. We used frequentist network meta-analysis to compare the rates of PEP among patients who received prophylactic treatments as follows: class A, rectal nonsteroidal anti-inflammatory drugs; class B, prophylactic pancreatic stent; class C, aggressive hydration; or control, no prophylaxis or active control. We selected those studies that included patients with risk factors for PEP. Results: We identified 19 trials, comprising 4,328 participants. Class ABC (odds ratio [OR], 0.08; 95% confidence interval [CI], 0.03 to 0.24), class AC (OR, 0.10; 95% CI, 0.02 to 0.47), class AB (OR, 0.12; 95% CI, 0.05 to 0.26), class BC (OR, 0.13; 95% CI, 0.04 to 0.41), class A (OR, 0.16; 95% CI, 0.05 to 0.50), and class B (OR, 0.26; 95% CI, 0.14 to 0.46), were associated with a reduced risk of PEP as compared to that of the control. The most effective prophylaxis was ABC (0.87), followed by AC (0.68), AB (0.65), BC (0.56), A (0.49), and B (0.24) according to P-score. Conclusions: The results of this network meta-analysis suggest that the more prophylactic methods are employed, the better the outcomes. It appears that for patients with risk factors, we need to prevent PEP through the use of these well proven combination strategies.
Abstract
Background/Aims: The combinatorial effects of prophylactic methods for postendoscopic retrograde cholangiopancreatography pancreatitis (PEP) in patients with risk factors remain unclear. In this network meta-analysis, we compared the efficacy of various prophylactic strategies to decrease the risk of PEP among patients with risk factors. Methods: A systematic review was performed to identify randomized controlled trials from PubMed, Embase, and the Cochrane Library through July 2021. We used frequentist network meta-analysis to compare the rates of PEP among patients who received prophylactic treatments as follows: class A, rectal nonsteroidal anti-inflammatory drugs; class B, prophylactic pancreatic stent; class C, aggressive hydration; or control, no prophylaxis or active control. We selected those studies that included patients with risk factors for PEP. Results: We identified 19 trials, comprising 4,328 participants. Class ABC (odds ratio [OR], 0.08; 95% confidence interval [CI], 0.03 to 0.24), class AC (OR, 0.10; 95% CI, 0.02 to 0.47), class AB (OR, 0.12; 95% CI, 0.05 to 0.26), class BC (OR, 0.13; 95% CI, 0.04 to 0.41), class A (OR, 0.16; 95% CI, 0.05 to 0.50), and class B (OR, 0.26; 95% CI, 0.14 to 0.46), were associated with a reduced risk of PEP as compared to that of the control. The most effective prophylaxis was ABC (0.87), followed by AC (0.68), AB (0.65), BC (0.56), A (0.49), and B (0.24) according to P-score. Conclusions: The results of this network meta-analysis suggest that the more prophylactic methods are employed, the better the outcomes. It appears that for patients with risk factors, we need to prevent PEP through the use of these well proven combination strategies.
참고문헌 (45)
- Freeman ML, "Complications of endoscopic biliary sphincterotomy", N Engl J Med, 335, pp.909~918 (1996)
- Dumonceau JM, "ERCP-related adverse events : European Society of Gastrointestinal Endoscopy(ESGE)guideline", Endoscopy, 52, pp.127~149 (2020)
- Cheng CL, "Risk factors for post-ERCP pancreatitis : a prospective multicenter study", Am J Gastroenterol, 101, pp.139~147 (2006)
- Park CH, "Aggressive intravenous hydration with lactated Ringer’s solution for prevention of post-ERCP pancreatitis : a prospective randomized multicenter clinical trial", Endoscopy, 50, pp.378~385 (2018)
- Lee TH, "Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation : a multicenter, prospective, randomized study", Gastrointest Endosc, 76, pp.578~585 (2012)
- Kawaguchi Y, "Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography", World J Gastroenterol, 18, pp.1635~1641 (2012)
- Elmunzer BJ, "A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis", N Engl J Med, 366, pp.1414~1422 (2012)
- Radadiya D, "Efficacy of combining aggressive hydration with rectal indomethacin in preventing post-ERCP pancreatitis : a systematic review and network meta-analysis", J Clin Gastroenterol, 56, pp.e239~e249 (2022)
- Oh HC, "Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with a combination of pharmacological agents based on rectal non-steroidal anti-inflammatory drugs : a systematic review and network meta-analysis", J Gastroenterol Hepatol, 36, pp.1403~1413 (2021)
- Shou-Xin Y, "Rectal nonsteroidal anti-inflammatory drugs and pancreatic stents in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a network meta-analysis", Medicine(Baltimore), 99, pp.e22672~ (2020)
- Njei B, "Comparative effectiveness of pharmacologic and endoscopic interventions for prevention of post-ERCP pancreatitis : a network meta-analysis", Endosc Int Open, 8, pp.E29~E40 (2020)
- Mine T, "Clinical practice guideline for post-ERCP pancreatitis", J Gastroenterol, 52, pp.1013~1022 (2017)
- ASGE Standards of Practice Committee, "Adverse events associated with ERCP", Gastrointest Endosc, 85, pp.32~47 (2017)
- Salanti G, "Graphical methods and numerical summaries for presenting results from multipletreatment meta-analysis : an overview and tutorial", J Clin Epidemiol, 64, pp.163~171 (2011)
- Rucker G, "Ranking treatments in frequentist network meta-analysis works without resampling methods", BMC Med Res Methodol, 15, pp.58~ (2015)
- Rucker G, "Resolve conflicting rankings of outcomes in network meta-analysis : partial ordering of treatments", Res Synth Methods, 8, pp.526~536 (2017)
- IntHout J, "Plea for routinely presenting prediction intervals in meta-analysis", BMJ Open, 6, pp.e010247~ (2016)
- Higgins JP, "Consistency and inconsistency in network meta-analysis : concepts and models for multi-arm studies", Res Synth Methods, 3, pp.98~110 (2012)
- Nikolakopoulou A, "CINeMA : an approach for assessing confidence in the results of a network meta-analysis", PLoS Med, 17, pp.e1003082~ (2020)
- Brignardello-Petersen R, "Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis", J Clin Epidemiol, 93, pp.36~44 (2018)
- Smithline A, "Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients", Gastrointest Endosc, 39, pp.652~657 (1993)
- Tarnasky PR, "Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction", Gastroenterology, 115, pp.1518~1524 (1998)
- Fazel A, "Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study", Gastrointest Endosc, 57, pp.291~294 (2003)
- Ito K, "Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial", J Gastroenterol, 45, pp.1183~1191 (2010)
- Conigliaro R, "Pancreatic duct stenting for the duration of ERCP only does not prevent pancreatitis after accidental pancreatic duct cannulation : a prospective randomized trial", Surg Endosc, 27, pp.569~574 (2013)
- Cha SW, "Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study", Gastrointest Endosc, 77, pp.209~216 (2013)
- Yin HK, "Pancreatic stenting reduces post-ERCP pancreatitis and biliary sepsis in high-risk patients : a randomized, controlled study", Gastroenterol Res Pract, 2016, pp.9687052~ (2016)
- Murray B, "Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography", Gastroenterology, 124, pp.1786~1791 (2003)
- Lua GW, "Can rectal diclofenac prevent post endoscopic retrograde cholangiopancreatography pancreatitis?", Dig Dis Sci, 60, pp.3118~3123 (2015)
- Patil S, "Role of rectal diclofenac suppository for prevention and its impact on severity of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients", Gastroenterology Res, 9, pp.47~52 (2016)
- Khoshbaten M, "Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis", J Gastroenterol Hepatol, 23(7 Pt 2), pp.e11~e16 (2008)
- Andrade-Davila VF, "Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography : results of a controlled clinical trial", BMC Gastroenterol, 15, pp.85~ (2015)
- Mok SR, "Lactated Ringer’s solution in combination with rectal indomethacin for prevention of post-ERCP pancreatitis and readmission : a prospective randomized, double-blinded, placebo-controlled trial", Gastrointest Endosc, 85, pp.1005~1013 (2017)
- Sotoudehmanesh R, "Pharmacological prophylaxis versus pancreatic duct stenting plus pharmacological prophylaxis for prevention of post-ERCP pancreatitis in high risk patients : a randomized trial", Endoscopy, 51, pp.915~921 (2019)
- Sperna Weiland CJ, "Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis(FLUYT) : a multicentre, open-label, randomised, controlled trial", Lancet Gastroenterol Hepatol, 6, pp.350~358 (2021)
- Hyun Jik Lee, "Impact of Hospital Volume and the Experience of Endoscopist on Adverse Events Related to Endoscopic Retrograde Cholangiopancreatography: A Prospective Observational Study", Gut and Liver, 14(2), pp.257~264 (2020), 거트앤리버 소화기연관학회협의회
- Park Jin Myung, "Recent 5-Year Trend of Endoscopic Retrograde Cholangiography in Korea Using National Health Insurance Review and Assessment Service Open Data", Gut and Liver, 14(6), pp.833~841 (2020), 거트앤리버 소화기연관학회협의회[DOI]
- Lee Jae Min, "A National Survey on the Environment and Basic Techniques of Endoscopic Retrograde Cholangiopancreatography in Korea", Gut and Liver, 15(6), pp.904~911 (2021), 거트앤리버 소화기연관학회협의회[DOI]
- Tae Young Park, "Rectal NSAIDs-based combination modalities are superior to single modalities for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a network meta-analysis", The Korean Journal of Internal Medicine, 37(2), pp.322~339 (2022), 대한내과학회[DOI]
- Marta K, "Combined use of indomethacin and hydration is the best conservative approach for post-ERCP pancreatitis prevention : a network metaanalysis", Pancreatology, 21, pp.1247~1255 (2021)
- Dubravcsik Z, "Network meta-analysis of prophylactic pancreatic stents and non-steroidal anti-inflammatory drugs in the prevention of moderate-to-severe post-ERCP pancreatitis", Pancreatology, 21, pp.704~713 (2021)
- Akshintala VS, "Nonsteroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis : a systematic review and network meta-analysis", Lancet Gastroenterol Hepatol, 6, pp.733~742 (2021)
- Yang J, "Rectal nonsteroidal anti-inflammatory drugs for endoscopic retrograde cholangiopancreatography postoperative pancreatitis prevention : a network meta-analysis", J Clin Gastroenterol, 54, pp.305~313 (2020)
- Elmunzer BJ, "Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP : study protocol for a randomized controlled trial", Trials, 17, pp.120~ (2016)
- Murad MH, "How to read a systematic review and meta-analysis and apply the results to patient care : users’ guides to the medical literature", JAMA, 312, pp.171~179 (2014)